leadf
logo-loader
viewXPhyto Therapeutics Corp.

XPhyto Therapeutics partner 3A revives grant from German Ministry of Education and research

XPhyto (CSE: XPHY- OTC: XPHYF) CEO Hugh Rogers joined Steve Darling from Proactive Vancouver to bring news their German partner 3aDiagnostics and their contract research collaborators, have received a grant from the German Federal Ministry of Education and Research.

Roger telling Proactive how much that is grant is for and how they plan to use that capital as they continue to develop a pathogen-specific biosensor put into XPhyto’s dissolvable thin-film platform.

Quick facts: XPhyto Therapeutics Corp.

Price: 2.66 CAD

CSE:XPHY
Market: CSE
Market Cap: $154.31 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of XPhyto Therapeutics Corp. named herein, including the promotion by the Company of XPhyto Therapeutics Corp. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Xphyto Therapeutics provides update on their rapid COVID-19 screening test...

Xphyto Therapeutics (CSE: XPHY-OTC: XPHYF) CEO Hugh Rogers joined Steve Darling from Proactive Vancouver with news the company is releasing new details about their rapid, disposable, point-of-care lateral flow screening test to detect COVID-19. Rogers discusses what stage that testing is at...

1 week, 4 days ago

2 min read